Malaria: all 1,315 studies
Page 6 of 14. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.
- Primaquine Enantiomers in G6PD Deficient Human VolunteersCompletedNCT04073953Phase 1
- Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge ModelCompletedNCT04072302Phase 1
- P. Falciparum Infection Dynamics and Transmission to Inform EliminationStatus unknownNCT04053907Not applicable
- Study to Assess Efficacy of Artemether-lumefantrine Prophylaxis Against Forest Malaria in Cambodia (PAL_Cambodia)CompletedNCT04041973Not applicable
- Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and UgandaCompletedNCT04037332
- A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated MalariaWithdrawnNCT04020653Phase 2
- Determine the Tolerability and Safety of Atovaquone-proguanil (ATV-PG) Co-administered With Amodiaquine (AQ)CompletedNCT04002687Phase 1
- TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance StudyCompletedNCT03998839
- Diagnostic and Prognostic Biomarkers for Childhood Bacterial PneumoniaCompletedNCT03996967
- Molecular Diagnostic Methods for Detection of Plasmodium KnowlesiCompletedNCT03988296
- VAC 072-An Efficacy Study of R21/MM in Different Dose SchedulesCompletedNCT03970993Phase 1/2
- Effectiveness of Malaria Camps as Part of the Odisha State Malaria Elimination DriveCompletedNCT03963869Not applicable
- Performance Evaluation of Malaria Plus RDTsStatus unknownNCT03960632
- Malaria In Pregnancy in Central IndiaStatus unknownNCT03955263
- A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan AdultsTerminatedNCT03947190Phase 2
- Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP)Status unknownNCT03944317Not applicable
- A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)CompletedNCT03939104Phase 3
- Efficacy of Two Dual Active Ingredient Long Lasting Insecticidal Nets for Control of Malaria Transmitted by Pyrethroid Resistant Vectors in BeninCompletedNCT03931473Not applicable
- Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic AreasCompletedNCT03916003Phase 4
- VAC063C: A Study to Assess Repeat Blood-stage P. Falciparum InfectionCompletedNCT03906474Not applicable
- Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic AreasCompletedNCT03897673Not applicable
- To Assess the Safety, Immunogenicity and Efficacy of VLPM01 in Healthy, Malaria-Naïve VolunteersCompletedNCT03867331Phase 1
- A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan AfricaCompletedNCT03855995
- Pyramax in Asymptomatic Carriers of P. Falciparum MonoinfectionsStatus unknownNCT03814616Phase 2
- Malaria Vaccine Pilot EvaluationCompletedNCT03806465
- Efficacy and Safety of Artesunate + Amodiaquine With SLD of Primaquine for Treatment of Falciparum Malaria in ZanzibarCompletedNCT03773536Phase 4
- Efficacy of Artesunate + Amodiaquine Versus Artemether-lumefantrine for Falciparum Malaria in Zanzibar, 2005CompletedNCT03768908Phase 4
- Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in ZanzibarCompletedNCT03764527Phase 4
- LAMP Detection of Malaria in PREGnancy (LAMPREG) TrialCompletedNCT03754322Not applicable
- Drug Combinations of Atovaquone-Proguanil (AP) With ACTStatus unknownNCT03726593Phase 4
- Plasmodium and Other Parasites in Pregnant Women and Children Around Margibi and Montserrado Counties, LiberiaCompletedNCT03719599
- An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAPCompletedNCT03707353Phase 1/2
- P. Falciparum Infection Dynamics and Transmission to Inform Elimination (INDIE-1a)CompletedNCT03705624Not applicable
- Evaluation of a New Malaria Control Strategy Amongst Gold Miners Working Illegally in French Guiana (Malakit)CompletedNCT03695770Not applicable
- Transmission Dynamics of Residual and Re-emerging Malaria in the Amazon: Defining a Roadmap to Malaria EliminationStatus unknownNCT03689036
- Improving Maternal heAlth by Reducing Malaria in African HIV WomenCompletedNCT03671109Phase 3
- Drug Resistance Among Asymptomatic InfectionCompletedNCT03648411
- Monitoring of Perfusion in Sepsis and MalariaCompletedNCT03641534
- Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in TanzaniaCompletedNCT03640403Phase 3
- Evaluating the Effects of Community Delivery of Malaria Intermittent Preventive Treatment on Pregnant Women and BabiesCompletedNCT03600844Not applicable
- Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-PyrimethamineStatus unknownNCT03599596Phase 1
- Malaria in Strasbourg University HospitalStatus unknownNCT03594084
- Regimen Optimization Trial of PfSPZ Vaccine in Equatorial GuineaCompletedNCT03590340Phase 1
- rCSP/AP10-602 [GLA-LSQ] Vaccine TrialCompletedNCT03589794Phase 1
- A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and InfantsCompletedNCT03580824Phase 1/2
- Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria EliminationCompletedNCT03576313Phase 3
- Community Access to Rectal Artesunate for MalariaCompletedNCT03568344
- Efficacy of Three Novel Bi-treated Long Lasting Insecticidal NetsCompletedNCT03554616Not applicable
- Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient PatientsCompletedNCT03529396Phase 2
- Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese ChildrenCompletedNCT03521973Phase 2
- Evaluation of a Digital Microscope for MalariaCompletedNCT03512678
- Evaluation of the Performance of a hsRDT Versus cRDT in Reactive Case Detection of Malaria InfectionsStatus unknownNCT03511443Not applicable
- Routine Antenatal Care Versus Screening and Treatment of Malaria in Pregnancy in RwandaCompletedNCT03508349Not applicable
- Susceptibility of Gambian Adults to PfSPZ-Challenge Infection in the Controlled Human Malaria Infection ModelCompletedNCT03496454Not applicable
- Safety and Pharmacokinetics Study of DM1157 to Treat MalariaTerminatedNCT03490162Phase 1
- Dynamics of Subclinical Malaria: Preliminary StudyCompletedNCT03483571
- Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New GuineaCompletedNCT03462615
- Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan ChildrenCompletedNCT03452475Phase 3
- Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine CompoundsCompletedNCT03436160Early Phase 1
- Preventing Mental Health Problems After Childhood Severe MalariaCompletedNCT03432039Not applicable
- Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland TanzaniaCompletedNCT03431714Phase 4
- Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian AdultsCompletedNCT03420053Phase 1
- Prospective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum MalariaWithdrawnNCT03394976
- Efficacy And Safety Of AL For The Treatment Of Uncomplicated Falciparum Malaria In Mainland TanzaniaCompletedNCT03387631
- Malaria Genetic SurveillanceStatus unknownNCT03384498
- Malaria Genetic Surveillance in CambodiaCompletedNCT03384472
- Study of Controlled Human Plasmodium Vivax InfectionCompletedNCT03377296Not applicable
- Assessing the Effectiveness of Community Delivery of Intermittent Preventive Treatment in Pregnancy (IPTp) in MalawiCompletedNCT03376217Not applicable
- Single Low-dose Primaquine Efficacy and Safety.CompletedNCT03352843Phase 4
- Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Malaria Infection in Malaria Naïve AdultsCompletedNCT03341754Phase 1
- A Retrospective Study of Severe Plasmodium VivaxCompletedNCT03307369
- Community Dynamics of Malaria Transmission and Mosquito Feeding in Bancoumana, MaliCompletedNCT03304704
- Molecular Basis of Erythrocyte Invasion by Plasmodium Vivax Into Duffy-Negative Erythrocytes in MaliCompletedNCT03304691
- Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria ProphylaxisWithdrawnNCT03278808Phase 2
- Empirical ANtibiotic THErapy in Adults Hospitalised With MalariaCompletedNCT03224052
- Prevalence Survey of Antimalarial Drug Resistance MarkersCompletedNCT03217851
- DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in BrazilCompletedNCT03208907Phase 3
- Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in AfricaCompletedNCT03208179Phase 3
- A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2CompletedNCT03203421Phase 1/2
- Cohort Event Monitoring Study of Pyramax®CompletedNCT03201770Phase 4
- Dried Leaf Artemisia (DLA) Compared to Artemisinin Combination Therapy (ACT) vs MalariaWithdrawnNCT03199755Phase 2
- Chemoprotective Activity of MMV390048 in PfSPZ Challenge ModelWithdrawnNCT03195387Phase 1
- Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant WomenCompletedNCT03172221
- Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO SporozoitesCompletedNCT03168854Phase 1
- Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch VolunteersCompletedNCT03163121Phase 1
- ELISA Validation of Hypersensitive Rapid Diagnostic Test Results for Detection of P. FalciparumCompletedNCT03132402
- Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic AreasCompletedNCT03128515Phase 3
- A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of AdministrationCompletedNCT03084289Phase 1
- Insecticide Resistance Management in Burkina Faso and Côte D'IvoireCompletedNCT03074435Phase 3
- Effect of Paracetamol on Renal Function in Plasmodium Knowlesi MalariaCompletedNCT03056391Phase 3
- Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in MaliCompletedNCT03035305Not applicable
- A Systems Biology Approach to Malaria ImmunityCompletedNCT03014258Phase 1
- Efficacy and Safety of IPTp-DP Versus IPTp-SP in MalawiCompletedNCT03009526Phase 3
- Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian AdultsCompletedNCT02996695Phase 1
- Assessing Model Parameters for Applying the Retinol Isotope Dilution (RID) MethodCompletedNCT02996513Not applicable
- Epidemiology of Malaria in Ubon Ratchathani, ThailandStatus unknownNCT02991963
- Evaluation of Community-based Mass Screening and Treatment for Malaria in Western KenyaCompletedNCT02987270Phase 3
- Impact of Malaria on Pregnant Women in Ouelessebougou, MaliCompletedNCT02974608
- Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara AfricaCompletedNCT02974348Phase 3
- Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human VolunteersCompletedNCT02963324Phase 1